Executive Director / CEO
This analysis benchmarks the total compensation of Suzanne Wilkison, Executive Director / CEO ($145,846) against every comparable organization that fit the selection criteria — 153 in total — drawn systematically from IRS Form 990 filings, not a hand-picked subset.
Compensation sits at approximately the 88th percentile of comparable organizationswithin the typical range
Benchmarked executive: Suzanne Wilkison — reported title “PRESIDENT”, a direct title match to the Executive Director / CEO role.
Each figure is Form 990 Part VII columns D + F (reportable pay plus other compensation and benefits; column F may include amounts from related organizations), normalized to NC cost of living (BEA RPP, 2023) and to its filing year (CPI-U); the reported amount is on each linked 990.
| Organization | State | Revenue | Matched title | Comp (reported) | Comp (adjusted) | FY |
|---|---|---|---|---|---|---|
| Knox Martin Foundation | GA | $488,266 | President/ce | $90,000 | $90,167 | 2023 |
| Tom Slick Memorial Trust For Sw | TX | $487,198 | President & Ceo | $65,374 | $65,158 | 2023 |
| Central New York Lyme And | NY | $486,936 | Executive Director | $107,120 | $93,680 | 2024 |
| American Board Of Medical Specialties | IL | $484,417 | President & Ceo | $114,596 | $112,255 | 2023 |
| American Cochlear Implant Alliance | VA | $483,427 | Executive Director | $201,375 | $188,177 | 2024 |
| Jayden Deluca Foundation Inc | ID | $492,957 | Executive Director | $28,300 | $29,997 | 2023 |
| Parkinson Association Of | NC | $482,140 | Executive Dir. | $78,138 | $78,138 | 2024 |
| Odylia Therapeutics Inc | GA | $482,047 | Ceo/cso | $225,220 | $219,164 | 2024 |
| Veterans Research & Education | OK | $493,862 | Executive Di | $51,364 | $54,738 | 2024 |
| St Louis Life Sciences Project | MO | $479,877 | President/secretary/treasu | $201,834 | $213,002 | 2023 |
| Global Vitiligo Foundation | PA | $478,511 | Executive Director | $83,694 | $83,161 | 2023 |
| Autism Tree Project Inc | CA | $477,889 | Executive Dir. | $90,000 | $75,213 | 2024 |
| Cancollaborate Inc | MA | $471,902 | President | $52,083 | $46,633 | 2023 |
| Minneapolis Radiology And Vascular | MN | $504,944 | President | $8,034 | $7,683 | 2024 |
| Mycoses Study Group Education And | AL | $470,737 | Executive Director (Non-vo | $26,400 | $27,603 | 2024 |
| Genetic Information Research Institute | CA | $506,275 | Trustee | $129,149 | $107,930 | 2024 |
| The Myocarditis Foundation | TX | $468,356 | Executive Director | $107,000 | $103,587 | 2024 |
| New Jersey Institute For Medical | NJ | $513,625 | Chairman | $93,000 | $80,361 | 2024 |
| Dorn Research Institute Inc | SC | $460,393 | Executive Di | $125,000 | $126,207 | 2024 |
| Dragonheart Vermont Inc | VT | $516,116 | Former Exec Dir | $30,973 | $30,171 | 2024 |
| La Jolla Infectious Disease Institute | CA | $516,793 | President, Ceo | $28,033 | $24,119 | 2023 |
| Massachusetts Society For | MA | $457,668 | President | $121,978 | $109,216 | 2023 |
| Pediatric Heart Transplant Society Foundation | AL | $519,047 | Executive Director | $80,000 | $86,115 | 2023 |
| American Society For Metabolic And | FL | $455,062 | Dir/exec Dir '24 | $47,782 | $43,442 | 2024 |
| Academy For Health & Lifespan | NY | $454,339 | Executive Dir. | $60,927 | $54,857 | 2023 |
Comp (reported) is the figure on each organization's Form 990 (columns D + F); Comp (adjusted) normalizes it to NC cost of living and 2024 dollars. Click any organization to verify the figure on ProPublica.
Comparable organizations were drawn from electronically filed IRS Form 990 returns and matched on sector (NTEE code), budget (a size-adaptive revenue band that tightens as the organization grows), and geography (same-state first, broadening only when too few peers qualify); every organization within the band forms the peer set. To compare fairly across regions and years, peer compensation is normalized to NC cost of living (BEA Regional Price Parities, 2023) and to the subject's filing year (CPI-U). The figure benchmarked is Form 990 Part VII, Section A, columns D + F — reportable pay plus other compensation, benefits, and deferred amounts (column F may include amounts from related organizations) — with the chief executive matched by role. Related-organization amounts (column E) and institutional trustees are excluded. Full methodology: peerbasis.org/methodology.
Sensitivity — the subject's percentile under alternative compensation definitions:
| Basis | Subject percentile |
|---|---|
| Total compensation (D + F), cost-of-living + inflation adjusted — the PeerBasis default | 88th |
| Total compensation (D + F), as reported (no adjustments) | 85th |
| Reportable pay only (column D), adjusted | 82nd |
| All sources (D + E + F), adjusted | 78th |
If the percentile moves materially across these definitions, the result is sensitive to methodology choices, and the board should weigh which basis best fits its facts.
Compensation paid by a tax-exempt organization is presumed reasonable — shifting the burden to the IRS — when three requirements are met. This report supplies the comparability data for the second. The board should record the following in its minutes concurrently with its decision:
Draft board minutes — executive compensation
Sources: IRS Form 990 e-file data (apps.irs.gov); IRS Business Master File (NTEE classification). Every figure traces to an original public filing — click any organization above to verify it on ProPublica. PeerBasis is a service of Prismind Analytics; its methodology is published, was commissioned for independent adversarial review, and discloses its own limitations. This report is comparability data to support a board's good-faith determination under IRC 4958; it is not legal or tax advice. Generated by PeerBasis on June 9, 2026.